BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27685633)

  • 1. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.
    Yang Z; Li X; Yang Y; He Z; Qu X; Zhang Y
    Cell Death Dis; 2016 Sep; 7(9):e2389. PubMed ID: 27685633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in osteosarcoma.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis.
    Xu S; Gong Y; Yin Y; Xing H; Zhang N
    Biomed Pharmacother; 2020 Jul; 127():110141. PubMed ID: 32334375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
    Li Z; Dou P; Liu T; He S
    Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
    Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
    Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA miR210HG Sponges miR-503 to Facilitate Osteosarcoma Cell Invasion and Metastasis.
    Li J; Wu QM; Wang XQ; Zhang CQ
    DNA Cell Biol; 2017 Dec; 36(12):1117-1125. PubMed ID: 28972855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
    Yang Y; Wang S; Li T
    Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: emerging players in osteosarcoma.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 Mar; 37(3):2811-6. PubMed ID: 26718212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNAs in pancreatic cancer.
    Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
    Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
    Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
    Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.